Shenzhen Edge Medical Co., Ltd. (HKG:2675)
Hong Kong · Delayed Price · Currency is HKD 36.86
+2.18 (6.29%)
Sep 30, 2026, 4:08 PM HKT
Shenzhen Edge Medical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 1,260 | 86.04 | 119.81 | 155.32 |
Short-Term Investments | 59.93 | 109.03 | 107.2 | - |
Trading Asset Securities | 536.82 | 727.81 | 876.5 | 1,067 |
Cash & Short-Term Investments | 1,857 | 922.89 | 1,104 | 1,222 |
Cash Growth | 82.91% | -16.37% | -9.72% | - |
Accounts Receivable | 240.67 | 226.53 | 55.3 | 17.09 |
Other Receivables | 45.12 | 18.83 | 20.37 | 16.53 |
Receivables | 285.79 | 245.36 | 75.66 | 33.62 |
Inventory | 158.14 | 136.11 | 73.71 | 77.16 |
Other Current Assets | 57.42 | 29.99 | 11.9 | 17.3 |
Total Current Assets | 2,358 | 1,334 | 1,265 | 1,350 |
Property, Plant & Equipment | 94.88 | 42.05 | 92.3 | 88.69 |
Long-Term Investments | 0.12 | 0.13 | - | 103.69 |
Other Intangible Assets | 0.19 | 0.09 | 1.16 | 2.98 |
Long-Term Accounts Receivable | 19.86 | 4 | - | - |
Other Long-Term Assets | 9.47 | 5.12 | 2.49 | 9.94 |
Total Assets | 2,483 | 1,386 | 1,361 | 1,556 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Accounts Payable | 20.34 | 22.8 | 8.3 | 5.88 |
Accrued Expenses | 25.62 | 37.04 | 32.83 | 34.87 |
Current Portion of Leases | 10.86 | 4.25 | 7.7 | 8.01 |
Current Unearned Revenue | 7.85 | 7.73 | 5.82 | 4.62 |
Other Current Liabilities | 56.32 | 92.63 | 32.19 | 24.16 |
Total Current Liabilities | 120.98 | 164.45 | 86.84 | 77.55 |
Long-Term Leases | 31.95 | 5.64 | 10.33 | 18.72 |
Long-Term Unearned Revenue | 19.85 | 16.94 | 3.61 | 21.04 |
Total Liabilities | 172.78 | 187.03 | 100.77 | 117.3 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Common Stock | 391.88 | 360 | 360 | 360 |
Additional Paid-In Capital | 2,717 | 1,556 | 1,556 | 1,556 |
Retained Earnings | -828.99 | -809.73 | -721.12 | -502.62 |
Comprehensive Income & Other | 89.39 | 92.13 | 64.77 | 24.65 |
Shareholders' Equity | 2,310 | 1,199 | 1,260 | 1,438 |
Total Liabilities & Equity | 2,483 | 1,386 | 1,361 | 1,556 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | 42.81 | 9.89 | 18.03 | 26.73 |
Net Cash (Debt) | 1,814 | 913 | 1,085 | 1,196 |
Net Cash Growth | 81.12% | -15.89% | -9.21% | - |
Net Cash Per Share | 4.84 | 2.54 | 3.02 | 3.32 |
Filing Date Shares Outstanding | 390.06 | 391.88 | 424.12 | 360 |
Total Common Shares Outstanding | 390.06 | 360 | 360 | 360 |
Working Capital | 2,237 | 1,170 | 1,178 | 1,273 |
Book Value Per Share | 5.92 | 3.33 | 3.50 | 4.00 |
Tangible Book Value | 2,310 | 1,199 | 1,259 | 1,435 |
Tangible Book Value Per Share | 5.92 | 3.33 | 3.50 | 3.99 |
Machinery | - | 58.67 | 72.37 | 47.06 |
Construction In Progress | - | 0.15 | - | - |
Leasehold Improvements | - | 22.48 | 22.37 | 15.02 |